Insider · CIK 0001601583

Young Matthew P.

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001601583

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+59K sh	—	—	59,000
2025-06-11	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2024-05-15	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38K sh	—	—	38,000
2023-06-14	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-15	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-07-01	PRA Health Sciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7,127 sh	—	—	0
2021-06-16	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-06-01	PRA Health Sciences, Inc.A Award	Director	AAward	+250 sh	—	—	7,127
2020-06-17	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-05-18	PRA Health Sciences, Inc.A Award	Director	AAward	+1,324 sh	—	—	6,877
2019-06-19	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2019-06-03	PRA Health Sciences, Inc.A Award	Director	AAward	+1,436 sh	—	—	5,553
2019-03-06	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−1,152 sh	$135.41	−$156K	36,200
2019-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & CFO	FTax Payment	−1,267 sh	$135.82	−$172K	38,700
2019-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & CFO	FTax Payment	−1,348 sh	$135.82	−$183K	37,352
2019-02-28	JAZZJazz Pharmaceuticals plcA Award	EVP & CFO	AAward	+12K sh	—	—	39,967
2019-02-28	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	EVP & CFO	AAward	+714 sh	—	—	714
2019-02-28	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)A Award	EVP & CFO	AAward	+29.3K sh	—	—	29,286
2019-02-27	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−884 sh	$137.91	−$122K	27,967
2019-02-26	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−1,032 sh	$125.93	−$130K	29,885
2019-02-26	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & CFO	FTax Payment	−1,034 sh	$127.76	−$132K	28,851
2019-02-25	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & CFO	FTax Payment	−1,218 sh	$126.25	−$154K	30,917
2018-11-23	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$150.00	−$105K	32,068
2018-10-15	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$158.08	−$111K	32,768
2018-09-17	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$162.70	−$114K	33,468
2018-08-15	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$176.05	−$123K	34,168
2018-07-16	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$176.06	−$123K	34,868
2018-06-21	PRA Health Sciences, Inc.A Award	Director	AAward	+1,307 sh	—	—	4,117
2018-06-15	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$176.99	−$124K	35,568
2018-06-13	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2018-06-01	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP & CFO	MExercise/Conversion	+5,000 sh	$58.72	+$294K	41,268
2018-06-01	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−5,000 sh	$170.04	−$850K	36,268
2018-06-01	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP & CFO	MExercise/Conversion	−5,000 sh	—	—	12,192
2018-05-15	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−1,420 sh	$164.64	−$234K	36,203
2018-05-14	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & CFO	FTax Payment	−842 sh	$166.00	−$140K	37,623
2018-04-16	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$156.01	−$109K	38,465
2018-03-15	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$151.22	−$106K	39,165
2018-03-06	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−800 sh	$142.06	−$114K	40,217
2018-03-06	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−352 sh	$143.04	−$50.4K	39,865
2018-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP & CFO	FTax Payment	−1,348 sh	$143.39	−$193K	41,017
2018-03-01	JAZZJazz Pharmaceuticals plcA Award	EVP & CFO	AAward	+9,400 sh	—	—	42,365
2018-03-01	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	EVP & CFO	AAward	+710 sh	—	—	710
2018-03-01	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)A Award	EVP & CFO	AAward	+22.8K sh	—	—	22,790
2018-02-28	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−200 sh	$145.25	−$29K	33,984
2018-02-28	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−119 sh	$147.56	−$17.6K	33,865
2018-02-28	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−200 sh	$149.01	−$29.8K	33,665
2018-02-28	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−700 sh	$150.00	−$105K	32,965
2018-02-27	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−1,016 sh	$144.96	−$147K	35,690
2018-02-27	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−600 sh	$145.83	−$87.5K	35,090
2018-02-27	JAZZJazz Pharmaceuticals plcS Sale	EVP & CFO	SSale	−300 sh	$147.30	−$44.2K	34,790

Recent filings

Accepted (ET)
Jun 224
Young Matthew P.0001610717-26-000279
SEC(opens sec.gov)
Jun 134
Young Matthew P.0001610717-25-000214
SEC(opens sec.gov)
May 174
Young Matthew P.0001610717-24-000248
SEC(opens sec.gov)
Jun 164
Young Matthew P.0001610717-23-000181
SEC(opens sec.gov)
Jun 174
Young Matthew P.0001567619-22-013075
SEC(opens sec.gov)
Jul 14
Young Matthew P.0001104659-21-088359
SEC(opens sec.gov)
Jun 174
Young Matthew P.0001567619-21-012371
SEC(opens sec.gov)
Jun 34
Young Matthew P.0001104659-21-076362
SEC(opens sec.gov)
Jun 174
Young Matthew P.0001567619-20-012304
SEC(opens sec.gov)
May 204
Young Matthew P.0001104659-20-064309
SEC(opens sec.gov)
Jun 214
Young Matthew P.0001567619-19-013826
SEC(opens sec.gov)
Jun 54
Young Matthew P.0001104659-19-034065
SEC(opens sec.gov)
Mar 74
Young Matthew P.0001765581-19-000041
SEC(opens sec.gov)
Mar 44
Young Matthew P.0001765581-19-000029
SEC(opens sec.gov)
Feb 274
Young Matthew P.0001765581-19-000012
SEC(opens sec.gov)

Companies

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080